Staph blood infection study: understanding severity
Part of Infections clinical trials.
This study looks at different types of Staph aureus blood infections to understand which ones are more likely to cause severe illness or death. It may help doctors predict who needs more aggressive treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed Staphylococcus aureus infection in your blood (bacteremia).
- The infection is causing serious symptoms like fever, fast heart rate, or low blood pressure.
- You are not in palliative care (comfort-focused care) for this infection.
- Your blood culture did not show other types of bacteria besides Staph aureus.
- You are expected to live more than 2 days after the infection is detected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This study uses a special whole-body scan (PET/CT) to learn more about how a Staphylococcus aureus bloodstream infection behaves in the body. It may help doctors better understand infection severity and guide care for people with this diagnosis.
This study looks at whether giving two antibiotics early for a serious staph infection in the blood leads to better results than the standard one antibiotic. It uses existing hospital monitoring and follow-up visits to track progress.
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
Hear when a new Staphylococcus Aureus Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.